Cogent Biosciences, Inc. Employee Count
The employee counts Cogent Biosciences, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 258; Filing 2026-02-17; Lease expense per employee $15,538.76.
- 2024-12-31: Employees (as filed) 205; Filing 2025-02-25; Lease expense per employee $20,009.76.
- 2023-12-31: Employees (as filed) 164; Filing 2024-02-26; Lease expense per employee $27,335.37.
- 2022-12-31: Employees (as filed) 138; Filing 2023-03-14; Lease expense per employee $36,543.48.
- Available history
- 2022-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 258 | 2026-02-17 | $15,538.76 operating + variable |
| 2024-12-31 | 205 | 2025-02-25 | $20,009.76 operating + variable |
| 2023-12-31 | 164 | 2024-02-26 | $27,335.37 operating + variable |
| 2022-12-31 | 138 | 2023-03-14 | $36,543.48 operating + variable |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |